Palo Alto Networks (NASDAQ: PANW) maintains an Outperform rating from FBN Securities, with its stock price at $354.88 on July 1, 2026, reflecting a positive investment outlook. The company's ...

Constellium SE CSTM is poised to gain from solid momentum in its Aerospace & Transportation (A&T) segment. The segment's shipments surged 18% to 60 thousand metric tons in the first quarter of 2026.

Item 7.01 Regulation FDDisclosure. On June 30, 2026, representativesof the Company made a presentation to an investor (the “Investor Presentation”) using slides containing the information attachedto ...

Announcement on Receipt of an Inquiry Letter from the Shanghai Stock ExchangeThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for ...

Chicago, IL - July 1, 2026 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and ...

BanksIssuer Ratings (S&P/M/F): AAA/Aaa/AAAPlacement: 06.07.2026Tenor: Due 06.07.

Item 5.02 Departure of Certain Officers; Appointment of Certain Officers Effective June 30, 2026 (the “Effective Date”), PatrickFarrell has retired from his position as Chief Financial Officer of ...

If you purchased shares of Micron Technology (NASDAQ: MU) and Sandisk (NASDAQ: SNDK) stock at the beginning of the year, you look like an absolute genius right now. The stocks have performed ...

Announcement on Self-exercise Results of Stock Option Incentive Plan and Share Changes for Q2 2026The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy ...

MSC Industrial Direct reported impressive Q3 earnings per share (EPS) of $1.43, surpassing analyst estimates. The company achieved robust net sales of nearly $1.05 billion, marking a 7.8% ...

Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) have dropped 24% so far this year (through June 30). The biotech company is still a darling of Wall Street analysts, with 14 of 29 analysts following ...